Dyne Therapeutics, Inc. (DYN)
NASDAQ: DYN · Real-Time Price · USD
21.17
+0.37 (1.78%)
Nov 26, 2025, 4:00 PM EST - Market closed
Dyne Therapeutics Market Cap
Dyne Therapeutics has a market cap or net worth of $3.02 billion as of November 26, 2025. Its market cap has increased by 7.06% in one year.
Market Cap
3.02B
Enterprise Value
2.35B
1-Year Change
7.06%
Ranking
Category
Stock Price
$21.17
Market Cap Chart
Since the IPO on September 17, 2020, Dyne Therapeutics's market cap has increased from $790.90M to $3.02B, an increase of 282.30%. That is a compound annual growth rate of 29.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 26, 2025 | 3.02B | 26.11% |
| Dec 31, 2024 | 2.40B | 193.72% |
| Dec 29, 2023 | 816.30M | 35.12% |
| Dec 30, 2022 | 604.12M | -0.31% |
| Dec 31, 2021 | 606.03M | -36.50% |
| Dec 31, 2020 | 954.35M | 20.67% |
| Sep 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 988.81B |
| Johnson & Johnson | 500.07B |
| AbbVie | 402.36B |
| UnitedHealth Group | 298.66B |
| AstraZeneca | 290.32B |
| Merck & Co. | 259.69B |
| Novartis AG | 251.09B |
| Abbott Laboratories | 223.51B |